Send Inquiry

Request To Call Back

Ves-ATRA 10 Mg Capsule

Get a Price/Quote

MOQ : 100 Boxes

Ves-ATRA 10 Mg Capsule Specification

Origin of Medicine
India

Life Span
24 months from date of manufacture

Dosage Form
Oral solid dosage

Packaging Type
Blister pack

Brand Name
Ves-ATRA

Indication
Indicated for remission induction in patients with Acute Promyelocytic Leukemia (APL)

Salt Composition
All-trans Retinoic Acid 10 mg

Pacakaging (Quantity Per Box)
10 strips of 10 capsules each

Drug Type
Antineoplastic agent

Ingredients
All-trans Retinoic Acid

Physical Form
Capsule

Function
Used in the treatment of Acute Promyelocytic Leukemia (APL)

Recommended For
Adults, as prescribed by physician for Acute Promyelocytic Leukemia

Dosage
10 mg per capsule

Dosage Guidelines
Take as directed by the physician, do not exceed recommended dosage

Suitable For
Suitable for cancer patients under medical supervision

Quantity
100 capsules

Storage Instructions
Store below 25C in a dry place, protect from light and moisture

Contraindications
Known hypersensitivity to retinoids, pregnancy

HSN Code
30049099

Minimum Order Quantity
1 box (100 capsules)

Administration Route
Oral

Side Effects
Common side effects include headache, fever, dry skin, bone pain, and nausea

Prescription Required
Yes

Net Content
10 mg ATRA per capsule

Box Dimensions
(Approximate) 14cm x 8cm x 4cm

Marketed By
Intas Pharmaceuticals Ltd.

Colour
Yellowish-orange

Therapeutic Class
Anticancer

Regulatory Approval
Manufactured under GMP standards

Ves-ATRA 10 Mg Capsule Trade Information

Minimum Order Quantity
100 Boxes

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Boxes Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About Ves-ATRA 10 Mg Capsule

Capitalize on the clearance offer for the in-demand Ves-ATRA 10 Mg Capsule, a peerless anticancer agent manufactured by Intas Pharmaceuticals Ltd. Crafted with all-trans retinoic acid and distinguished by its magnificent yellowish-orange coloring, this lavish oral medication is prescribed for remission induction in adults with Acute Promyelocytic Leukemia (APL). Regulatory approval ensures GMP compliance, guaranteeing exceptional quality. Each blister-packed box contains 100 capsules, making it ideal for clinical settings. Take advantage now-supplies are limited for discerning professionals seeking superior efficacy.

Expanded Uses & Application Details

Ves-ATRA 10 Mg Capsule, while indicated primarily for Acute Promyelocytic Leukemia (APL), exemplifies peerless precision in targeted cancer therapies. Administered orally under medical supervision, its function as an antineoplastic agent ensures optimal patient care. The capsule is suitable for adults and is strictly prescription-based, restricting its use to patients selected by healthcare professionals. As an oral solid dosage form, the active component, all-trans retinoic acid, works systemically upon ingestion to help induce remission.

Export Markets, Sample Policy & Order Details

Ves-ATRA 10 Mg Capsule has found a significant customer base in global pharmaceutical markets. Packing & dispatch are executed swiftly upon receipt of a confirmed purchase order, ensuring prompt delivery to eligible buyers at the lowest price. Samples may be provided as per the supplier's sample policy, supporting informed purchasing decisions. Delivery time varies with location, but our strategic logistics guarantee timely arrival of bulk and retail consignments. Export is managed responsibly to preserve efficacy.

FAQ's of Ves-ATRA 10 Mg Capsule:

Q: How should Ves-ATRA 10 Mg Capsule be used for best results?

A: Ves-ATRA 10 Mg Capsule should be taken orally, strictly as directed by the prescribing physician. Follow the dosage instructions carefully and do not exceed the recommended amount. Continuous supervision by a medical professional is essential.

Q: What are the potential side effects of Ves-ATRA 10 Mg Capsule?

A: Common side effects may include headache, fever, dry skin, bone pain, and nausea. If you experience severe reactions or allergic symptoms, contact your healthcare provider immediately.

Q: When is Ves-ATRA 10 Mg Capsule indicated for use?

A: This medication is indicated for remission induction in patients diagnosed with Acute Promyelocytic Leukemia (APL). It should not be used without a confirmed diagnosis and professional prescription.

Q: Where should Ves-ATRA 10 Mg Capsule be stored for maximum efficacy?

A: Store the capsules below 25C in a dry, cool place away from light and moisture to maintain potency. Keep it securely out of reach of children.

Q: What is the process for placing a bulk order for Ves-ATRA 10 Mg Capsule?

A: To place a bulk or wholesale order, submit a formal purchase order to the supplier or authorized trader. Packing and dispatch will be scheduled immediately after order confirmation and payment receipt.

Q: What contraindications should a patient be aware of before taking Ves-ATRA 10 Mg Capsule?

A: Ves-ATRA is contraindicated in individuals with known hypersensitivity to retinoids and during pregnancy. Always discuss your medical history with your physician before starting treatment.

Tell us about your requirement